Tolemy â The AI-native virtual cell platform for therapeutic development and manufacture.
Location: United Kingdom
Total raised: $1.64M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.05.2026 | Pre-Seed | $1.64M | JME Ventur... |
Mentions in press and media 5
| Date | Title | Description |
| 14.05.2026 | Tolemy Bio Funding Powers AI-Native Platform for Predictable Cell Biology | Tolemy Bio, an innovative biotech startup, recently raised €1.4 million in pre-seed funding. This investment propels Orbit, their AI-native software. Orbit provides a "virtual cell" intelligence layer. It empowers scientists to un... |
| 13.05.2026 | Tolemy Bio Raises €1.4 Million Pre-Seed To Build AI-Native Platform For Understanding Cellular Systems | Tolemy Bio, the London-based biology software startup, has raised €1.4 million in pre-seed funding to develop Orbit, an AI-native software platform designed to help scientists understand, predict, and direct cellular behavior. The round was... |
| 12.05.2026 | Tolemy Bio Raises €1.4M in Pre-Seed Funding | Tolemy Bio, a Cambridge, UK- and Barcelona, Spain-based biotech startup, raised €1.4M in pre-seed funding. The round was led by Norrsken Evolve, with participation from Big Sur Ventures, JME Ventures, Masia, and a new UK stealth fund. The c... |
| 12.05.2026 | Tolemy Bio lands €1.4M to power AI-driven cell biology | Cambridge-based biotech startup Tolemy Bio has raised €1.4 million in pre-seed funding to advance its AI-enabled technology for cell biology research and biopharma development. The round was led by Norrsken Evolve, with participation from B... |
| - | Tolemy Bio | “Tolemy — The AI-native virtual cell platform for therapeutic development and manufacture.” |